NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment

NCT05627674

Enrolling By InvitationNA

Sponsor: Washington University School of Medicine

Conditions: Smoking, Smoking Cessation, Tobacco Use Cessation

Interventions: Usual Care, RiskProfile-Clin, RiskProfile-Gen

Countries: United States

This trial tests the effects of two versions of RiskProfile, a clinically-informed and a genetically-informed version of a patient-specific risk feedback tool, in comparison to usual care, on lung cancer screening and tobacco treatment. The trial assesses the multilevel effects of these precision risk feedback tools on the likelihood of clinicians to order lung cancer screening and tobacco treatment and of their patients to utilize these cancer prevention interventions.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

CLINICIANS:

\- Primary care clinician with active caseload in participating clinics

PATIENTS:

* Patient of participating primary care clinician
* Lung cancer screening naïve
* Between 50 to 80 years of age, inclusive
* Current or former smokers
* Pack years ≥ 20
* English-speaking

Exclusion Criteria:

PATIENTS:

* Lung cancer diagnosis
* Current order placed for lung cancer screening

Locations (1)

St Louis, Missouri, United States